Follow
Karen Elta Anderson
Karen Elta Anderson
Verified email at georgetown.edu - Homepage
Title
Cited by
Cited by
Year
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED] Report of the Quality Standards …
JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ...
Neurology 66 (7), 996-1002, 2006
6742006
Brain networks associated with cognitive reserve in healthy young and old adults
Y Stern, C Habeck, J Moeller, N Scarmeas, KE Anderson, HJ Hilton, ...
Cerebral cortex 15 (4), 394-402, 2005
5442005
The clinically important difference on the unified Parkinson's disease rating scale
LM Shulman, AL Gruber-Baldini, KE Anderson, PS Fishman, SG Reich, ...
Archives of neurology 67 (1), 64-70, 2010
5352010
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease
LM Shulman, LI Katzel, FM Ivey, JD Sorkin, K Favors, KE Anderson, ...
JAMA neurology 70 (2), 183-190, 2013
4312013
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
4142012
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis
N Scarmeas, E Zarahn, KE Anderson, CG Habeck, J Hilton, J Flynn, ...
Archives of neurology 60 (3), 359-365, 2003
3742003
The evolution of disability in Parkinson disease
LM Shulman, AL Gruber‐Baldini, KE Anderson, CG Vaughan, SG Reich, ...
Movement disorders 23 (6), 790-796, 2008
3422008
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ...
Neurology 85 (14), 1240-1249, 2015
3282015
Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease
GM Pontone, JR Williams, KE Anderson, G Chase, SA Goldstein, S Grill, ...
Movement disorders: official journal of the Movement Disorder Society 24 (9 …, 2009
3272009
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
E van Duijn, D Craufurd, AAM Hubers, EJ Giltay, R Bonelli, H Rickards, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (12), 1411-1418, 2014
2962014
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease
DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative, ...
Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010
2732010
Subregional neuroanatomical change as a biomarker for Alzheimer's disease
D Holland, JB Brewer, DJ Hagler, C Fennema-Notestine, AM Dale, ...
Proceedings of the National Academy of Sciences 106 (49), 20954-20959, 2009
2432009
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects
N Scarmeas, E Zarahn, KE Anderson, J Hilton, J Flynn, RL Van Heertum, ...
Neuroimage 19 (3), 1215-1227, 2003
2062003
Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study
HH Fernandez, SA Factor, RA Hauser, J Jimenez-Shahed, WG Ondo, ...
Neurology 88 (21), 2003-2010, 2017
1872017
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
1852021
A comparison of nine scales to detect depression in Parkinson disease: which scale to use?
JR Williams, ES Hirsch, K Anderson, AL Bush, SR Goldstein, S Grill, ...
Neurology 78 (13), 998-1006, 2012
1812012
Vascular burden and Alzheimer disease pathologic progression
RY Lo, WJ Jagust, M Weiner, P Aisen, M Weiner, P Aisen, R Petersen, ...
Neurology 79 (13), 1349-1355, 2012
1792012
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
KE Anderson, D Stamler, MD Davis, SA Factor, RA Hauser, J Isojärvi, ...
The Lancet Psychiatry 4 (8), 595-604, 2017
1762017
Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial
S Frank, CM Testa, D Stamler, E Kayson, C Davis, MC Edmondson, ...
Jama 316 (1), 40-50, 2016
1722016
Data analytics from Enroll‐HD, a global clinical research platform for Huntington's disease
GB Landwehrmeyer, CJ Fitzer‐Attas, JD Giuliano, N Gonçalves, ...
Movement disorders clinical practice 4 (2), 212-224, 2017
1602017
The system can't perform the operation now. Try again later.
Articles 1–20